David D. Meek's Net Worth
$852 Thousand
Who is David D. Meek?
David D. Meek does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Mirati Therapeutics, Inc., uniQure N.V., Entasis Therapeutics Holdings Inc., Baxalta Inc, ENDOCYTE INC, Fusion Pharmaceuticals Inc., and Cullinan Therapeutics, Inc..
SEC CIK
David D. Meek's CIK is 0001555337
Past Insider Trading and Trends
2022 was David D. Meek's most active year for acquiring shares with 8 total transactions. David D. Meek's most active month to acquire stocks was the month of May. 2016 was David D. Meek's most active year for disposing of shares, totalling 6 transactions. David D. Meek's most active month to dispose stocks was the month of May. 2013 saw David D. Meek paying a total of $87,300.00 for 90,000 shares, this is the most they've acquired in one year. In 2022 David D. Meek cashed out on 83,025 shares for a total of $305,505.35, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Mirati Therapeutics, Inc. (MRTX) No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +144.64% | 89.38K |
—
|
—
| 151.17K |
Jan 20
| |||
Form 4
| -4.89% | -3.18K |
$42.38 | -$134,714.58 | 61.79K |
Jan 17
| |||
Form 4
| +90.19% | 30.81K |
$40.41 | -$186,551.95 | 64.97K |
Dec 19 - Dec 21
| |||
Form 4
|
∞
| 34.06K |
—
|
—
| 34.06K |
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
uniQure N.V. (QURE) Snapshot price: $5.42
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +39.90% | 8.08K |
—
|
—
| 28.33K |
Jun 19
| |||
Form 4
| -9.92% | -2.23K |
$5.12 | -$11,412.48 | 20.25K |
Jun 13
| |||
Form 4
| +39.89% | 6.41K |
$18.85 | -$43,166.50 | 22.48K |
Jun 13 - Jun 16
| |||
Form 4
| -2.36% | -389.00 |
$19.71 | -$7,667.19 | 16.07K |
Feb 27
| |||
Form 4
| +123.04% | 9.08K |
—
|
—
| 16.46K |
Jun 15
| |||
Form 4
| -7.54% | -602.00 |
$16.70 | -$10,053.40 | 7.38K |
Feb 28
| |||
Form 4
| +23.79% | 1.53K |
—
|
—
| 7.98K |
Feb 24
| |||
Form 4
| -7.26% | -505.00 |
$37.50 | -$18,937.50 | 6.45K |
Mar 2
| |||
Form 4
| +52.11% | 2.38K |
—
|
—
| 6.95K |
Feb 25
| |||
Form 4
| +82.26% | 2.06K |
—
|
—
| 4.57K |
Feb 27
| |||
Form 4
| -22.35% | -722.00 |
$62.19 | -$44,903.36 | 2.51K |
Jan 28
| |||
Form 4
|
∞
| 3.23K |
—
|
—
| 3.23K |
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Entasis Therapeutics Holdings Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -49.50K |
$2.20 | -$108,900.00 |
0
|
Jul 7 - Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 4
| +125.00% | 27.5K |
—
|
—
| 49.5K |
Jan 18
| |||
Form 4
|
∞
| 22K |
—
|
—
| 22K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Baxalta Inc No price found
EVP and President, Oncology
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -51.64K |
—
|
—
|
0
|
Jun 3
| |||
Form 4
| +110.23% | 27.05K |
$39.30 | -$36,470.40 | 51.59K |
Mar 3
| |||
Form 4
| -3.16% | -791.00 |
$35.03 | -$27,708.73 | 24.28K |
Sep 2
| |||
Form 4
|
∞
| 25.07K |
—
|
—
| 25.07K |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ENDOCYTE INC No price found
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 7.5K |
—
|
—
| 7.5K |
Feb 6
| |||
Form 4
|
—
|
0
|
$12.12 | -$67,700.00 |
0
|
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||